IL6 and neoplasm: In addition, the reduction of adipose tissue may also affect the release of inflammatory factors such as interleukin-6 and tumor necrosis factor-α, thus improving the metabolic state of the body and the tumor microenvironment and increasing the sensitivity of treatment (30, 31).